July 18, 2022, Montréal, Canada – Vantage BioTrials, a full-service Contract Research Organization (CRO), has on-boarded a robust technology solution to manage its growing demand of early/late phase and medical device clinical trials. Accuracy, flexibility, and speed in obtaining real-time data are crucial. During the last couple of years of the Covid-19 pandemic, Vantage BioTrials remained focused in identifying areas of development that will add value to the overall maintenance, tracking and successful completion of clinical trial milestones. By implementing the usage of a CTMS like Smartsheet, Vantage BioTrials is able to implement a solution that facilitates quicker response times to an evolving clinical trial landscape.
Evolving life sciences landscape requires availability of real-time data
“Before the pandemic began in 2020, Vantage BioTrials was actively evaluating different CTMS vendors. During our careful evaluation process, it was imperative that we involve our different departments to identify a suitable supplier that would fit our business model, allow ease of use and meet the demanding needs of our Sponsors”, said Vatche Bartekian, President, Vantage BioTrials. “As a specialized CRO, Vantage BioTrials continues to remain focused in its growth and to set a precedence that we will continue to effectively compete in this ever-changing global life sciences market, and offer the quality and expertise required to run highly complicated clinical studies across all phases of development”, added Mr. Bartekian.
About Vantage BioTrials
Vantage BioTrials is a Contract Research Organization that uses innovative clinical trial management strategies for the life science industry with a focus on patient safety & advancing new therapies to market. We offer pharmaceutical, biotech & medical device companies a complete and integrated set of full service clinical trial management solutions at a competitive value.
Contact us today at [email protected] and discover how we can add value to your next clinical trial program.